Committed to Medical Innovations
Every day—in research labs across eastern Massachusetts—investigators, doctors and nurses at Partners HealthCare are working to discover new treatment options, medical devices and technology to improve the lives and outcomes of patients. Partners HealthCare Innovation works directly with researchers at Brigham and Women’s Hospital, Massachusetts General Hospital, McLean Hospital and Spaulding Hospital to commercialize their innovations. It is our mission to enable commercialization through the best route for a given technology, and ensure that technologies can benefit patients.
RaNA Therapeutics today announced the company has relaunched as Translate Bio. Translate Bio is a leading biotechnology company pioneering the translation of RNA science into therapeutics promoting healthy gene expression in people living with debilitating genetic diseases.Read More
Partners HealthCare and GE Healthcare launch 10-year collaboration to integrate Artificial Intelligence into every aspect of the patient journey
Partners HealthCare and GE Healthcare today announced a 10-year collaboration to rapidly develop, validate and strategically integrate deep learning technology across the entire continuum of care. The collaboration will be executed through the newly formed Massachusetts General Hospital and Brigham and Women’s Hospital Center for Clinical Data Science and will feature co-located, multidisciplinary teams with…Read More
The 2018 World Medical Innovation Forum focuses on the advancements and opportunities of Artificial Intelligence. The event will bring together industry-leading CEOs, Partners' HIT experts, investors and deal makers to share perspectives on how cognitive computation, machine learning, and big date are having a transformative impact on patient care.